Login / Signup
So-Jin Kang
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 4
Top Topics
Drug Release
Combination Therapy
Room Temperature
Cardiovascular Risk Factors
Top Venues
Pharmaceutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
So-Jin Kang
,
Joo-Eun Kim
Development of Clinically Optimized Sitagliptin and Dapagliflozin Complex Tablets: Pre-Formulation, Formulation, and Human Bioequivalence Studies.
Pharmaceutics
15 (4) (2023)
So-Jin Kang
,
Joo-Eun Kim
Development of Clinically Optimized Sitagliptin and Dapagliflozin Complex Tablets: Pre-Formulation, Formulation, and Human Bioequivalence Studies.
Pharmaceutics
15 (4) (2023)
So-Jin Kang
,
Joo-Eun Kim
Development of Clinically Optimized Sitagliptin and Dapagliflozin Complex Tablets: Pre-Formulation, Formulation, and Human Bioequivalence Studies.
Pharmaceutics
15 (4) (2023)
So-Jin Kang
,
Joo-Eun Kim
Development of Clinically Optimized Sitagliptin and Dapagliflozin Complex Tablets: Pre-Formulation, Formulation, and Human Bioequivalence Studies.
Pharmaceutics
15 (4) (2023)